Novo-Passit, 30 pcs.

Pharmacotherapeutic group

Sedative of herbal origin

ATX code: N05CM

Pharmacological action

It is a combined medicine, the pharmacological activity of which is due to its constituent herbal extract components with predominantly sedative (sedative) action and guaifenesin, which has anxiolytic (anti-anxiety) effect.

Indications

– Neurasthenia and neurotic reactions accompanied by irritability, anxiety, fear, fatigue, distraction.
– “Manager syndrome” (condition of constant mental tension).
– Insomnia (mild forms).
– Headaches caused by nervous tension.
– Migraine.
– Functional disorders of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).
– As a symptomatic agent for neurocirculatory dystonia and menopausal syndrome.
– Itching dermatitis (atopic eczema and seborrheic, urticaria) caused by psychological stress.

Active ingredient

Composition

Composition (per 1 tablet)

Active ingredients:

New Passit extract dry (1:6.5) (obtained from valerian medicinal rhizomes with roots (5 h), melissa medicinal herb (2 h), St. John’s wort herb (5 h), hawthorn leaves and flowers (5 h), passiflora incarnata herb (1 h), common hops (5 h), black elderflower (2 h)) 157.5 mg; guaifenesin 200.0 mg

Supplementary substances:

Silica dioxide 2.0 mg, microcrystalline cellulose 96.0 mg, glyceryl tribegenate 10.0 mg, magnesium stearate 10.0 mg, lactose monohydrate to 800.0 mg

Shell:

Opadray “AMB 80W31115” green (polyvinyl alcohol 45.52%, titanium dioxide 26.5%, talc 20.0%, soy lecithin 2.0%, xanthan gum 0.48%, quinoline yellow dye 2.5%, iron oxide yellow dye 2.0%, indigo carmine dye 1.0%) 24.0 mg.

How to take, the dosage

Interaction

When taking Novo-Passit® and other drugs at the same time, their effect may be enhanced or weakened. Before starting to take the drug simultaneously with other medicines, you should consult your doctor.

The drug increases the effect of alcohol and other substances that depress the central nervous system.

The drugs used to relax the skeletal muscles (central myorelaxation) may increase the risk of side effects of the drug, primarily muscle weakness.

The Hypericum extract contained in the drug reduces the effectiveness of hormonal contraception, as well as drugs used primarily after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), drugs to treat AIDS, cardiovascular disease, bronchial disease and prevent thromboembolism.

Therefore, before starting Novo-Passit® against the background of the above drugs, a physician should be consulted.

Special Instructions

During the treatment of the drug you should not drink alcohol.
During the use of Novo-PassitÒ, especially in patients with fair skin, avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting the solarium).
If the symptoms persist or deteriorate during 7 days of the drug use, it is necessary to inform the attending physician.
Influence on the ability to drive vehicles and mechanisms
During the period of the drug use one should refrain from potentially dangerous activities requiring high concentration and quick psychomotor reactions (including driving vehicles and operating moving mechanisms).

Contraindications

Hypersensitivity to the components of the drug, especially to guaifenesin, lactose intolerance, lactase deficiency, glucose-galactose malabsorption, myasthenia, children under 12 years of age.

With caution

Acute gastrointestinal diseases, liver disease, alcoholism, brain disease or injury, epilepsy, children over 12 years of age.

Side effects

Overdose

Pregnancy use

In pregnancy the drug is prescribed only with absolute indications, if the expected effect for the mother exceeds the possible risk to the fetus.

Breastfeeding should be discontinued if the drug has to be used during lactation.